Abstract
Delineation of GPCR function and regulation has relied heavily on the available pharmacological tools to manipulate GPCR activity, inhibit GPCR interacting proteins, or modulate downstream signaling molecules. Where appropriate agents are unobtainable, alternative molecular methods have been developed to determine the specific roles that individual proteins play in GPCR regulation and signaling. One such method utilizes RNA interference (RNAi) to suppress the expression of endogenous target proteins. The discovery that double-stranded (ds)RNA was able to deplete cellular protein expression paved the way for the development of modern RNAi methods. Initial experiments utilized long strands of dsRNA, which were cleaved via the action of an RNase named Dicer, into shorter 21–23 nucleotide RNAs, termed small interfering (si)RNAs. These active RNAs are unwound and incorporated into the RNA-induced silencing complex, wherein the antisense targeting strand binds to the complementary region of the target protein mRNA, promoting its subsequent destruction. Modern RNAi techniques mimic this process introducing carefully designed highly specific dsRNA constructs to effectively silence target gene expression within cells, offering an attractive alternative to the expensive development and maintenance of knockout animals. The use of RNAi has revolutionized the study of GPCR function and regulation circumventing the concerns over “off-target” effects which surround the overexpression of wild-type or inactive versions of target proteins. However, most importantly RNAi enables the precise identification of the roles that endogenous proteins play in cellular processes without the requirement for knockout animals. This chapter will examine how RNAi techniques have shed light on not only the function of GPCRs but also how gene silencing has uncovered novel roles for proteins that regulate GPCR responsiveness and signaling.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Willets JM, Challiss RM, Nahorski SR (2003) Non-visual GRKs: are we seeing the whole picture? Trends Pharmacol Sci 24:626–633
Pitcher JA, Freedman NJ, Lefkowitz RJ (1998) G protein-coupled receptor kinases. Annu Rev Biochem 67:653–692
DeWire SM, Ahn S, Lefkowitz RJ et al (2007) β-arrestins and cell signaling. Annu Rev Physiol 69:483–510
Guo S, Kemphues KJ (1995) PAR-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81:611–620
Fire A, Montgomery MK, Kostas SA et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811
Sen GL, Blau HM (2006) A brief history of RNAi: the silence of the genes. FASEB J 20:1293–1299
Napoli C, Lemieux C, Jorgensen R (1990) Introduction of a chimeric chalcone synthase gene into Petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2:279–289
Romano N, Macino G (1992) Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol Microbiol 6:3343–3353
Shim MS, Kwon YJ (2010) Efficient and targeted delivery of siRNA in vivo. FEBS J 277:4814–4827
Desai AN, Standifer KM, Eikenburg DC (2004) Simultaneous α2B- and β2-adrenoceptor activation sensitizes the α2B-adrenoceptor for agonist-induced down-regulation. J Pharmacol Exp Ther 311:794–802
Pasquinelli AE (2002) MicroRNAs: deviants no longer. Trends Genet 18:171–173
Denli AM, Topps BB, Plasterk RH et al (2004) Processing of primary microRNAs by the Microprocessor complex. Nature 432:231–235
Gregory RI, Yan K, Amuthan G et al (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432:235–240
Lee Y, Jeon K, Lee JT et al (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21:4663–4670
Han J, Lee Y, Yeom KH et al (2004) The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18:3016–3027
Chendrimada TP, Gregory RI, Kumaraswamy E et al (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436:740–744
Nykanen A, Haley B, Zamore PD (2001) ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107:309–321
Schwarz DS, Hutvagner G, Haley B et al (2002) Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol Cell 10:537–548
Dykxhoorn DM, Novina CD, Sharp PA (2003) Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4:457–467
Erlinge D, Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4:1–20
Morris GE, Nelson CP, Everitt D et al (2011) G protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signalling. Cardiovasc Res 89:193–203
Morris GE, Nelson CP, Brighton PJ et al (2012) Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle. Am J Physiol Cell Physiol 302:C723–C734
Saxena H, Deshpande DA, Tiegs BC et al (2012) The GPCR OGR1 (GPR68) mediates diverse signalling and contraction of airway smooth muscle in response to small reductions in extracellular pH. Br J Pharmacol 166:981–990
Dann SG, Selvaraj A, Thomas G (2007) mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13:252–259
Wauson EM, Zaganjor E, Lee AY et al (2012) The G protein-coupled taste receptor T1R1/T1R3 regulates mTORC1 and autophagy. Mol Cell 47:851–862
Samson WK, Zhang JV, Avsian-Kretchmer O et al (2008) Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions. J Biol Chem 283:31949–31959
Yosten GL, Redlinger LJ, Samson WK (2012) Evidence for an interaction of neuronostatin with the orphan G protein-coupled receptor, GPR107. Am J Physiol Regul Integr Comp Physiol 303:R941–R949
Gurevich EV, Tesmer JJ, Mushegian A et al (2012) G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther 133:40–69
Penela P, Murga C, Ribas C et al (2010) The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol 160:821–832
Thal DM, Homan KT, Chen J et al (2012) Paroxetine is a direct inhibitor of G protein-coupled receptor kinase 2 and increases myocardial contractility. ACS Chem Biol 7:1830–1839
Casey LM, Pistner AR, Belmonte SL et al (2010) Small molecule disruption of Gβγ signaling inhibits the progression of heart failure. Circ Res 107:532–539
Sterne-Marr R, Tesmer JJ, Day PW et al (2003) G protein-coupled receptor Kinase 2/Gα q/11 interaction. A novel surface on a regulator of G protein signaling homology domain for binding Gα subunits. J Biol Chem 278:6050–6058
Shih M, Malbon CC (1994) Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and β-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization. Proc Natl Acad Sci U S A 91:12193–12197
Aiyar N, Disa J, Dang K et al (2000) Involvement of G protein-coupled receptor kinase-6 in desensitization of CGRP receptors. Eur J Pharmacol 403:1–7
Watanabe H, Xu J, Bengra C et al (2002) Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int 62:790–798
Willets JM, Parent JL, Benovic JL et al (1999) Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression. J Neurochem 73:1781–1789
Dautzenberg FM, Braun S, Hauger RL (2001) GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation. Am J Physiol Regul Integr Comp Physiol 280:R935–R946
Nagayama Y, Takana K, Hara T et al (1996) Involvement of G protein-coupled receptor kinase 5 in homologous desensitization of the thyrotropin receptor. J Biol Chem 271:10143–10148
Mundell SJ, Benovic JL, Kelly E (1997) A dominant negative mutant of the G protein-coupled receptor kinase 2 selectively attenuates adenosine A2 receptor desensitization. Mol Pharmacol 51:991–998
Chopineau M, Martinat N, Troispoux C et al (1997) Expression of horse and donkey LH in COS-7 cells: evidence for low FSH activity in donkey LH compared with horse LH. J Endocrinol 152:371–377
Ren XR, Reiter E, Ahn S et al (2005) Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci U S A 102:1448–1453
Kim J, Ahn S, Ren XR et al (2005) Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci U S A 102:1442–1447
Nobles KN, Xiao K, Ahn S et al (2011) Distinct phosphorylation sites on the β2-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin. Sci Signal 4:ra51
Guo Q, Subramanian H, Gupta K et al (2011) Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases. PLoS One 6:e22559
Morris GE, Nelson CP, Standen NB et al (2010) Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. Cardiovasc Res 85:424–433
Freedman NJ, Ament AS, Oppermann M et al (1997) Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G protein-coupled receptor kinase specificity. J Biol Chem 272:17734–17743
Smith MP, Ayad VJ, Mundell SJ et al (2006) Internalization and desensitization of the oxytocin receptor is inhibited by Dynamin and clathrin mutants in human embryonic kidney 293 cells. Mol Endocrinol 20:379–388
Willets JM, Brighton PJ, Mistry R et al (2009) Regulation of oxytocin receptor responsiveness by G protein-coupled receptor kinase 6 in human myometrial smooth muscle. Mol Endocrinol 23:1272–1280
Tobin AB, Butcher AJ, Kong KC (2008) Location, location, location…site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 29:413–420
Hasbi A, Devost D, Laporte SA et al (2004) Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2. Mol Endocrinol 18:1277–1286
Bremnes T, Paasche JD, Mehlim A et al (2000) Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem 275:17596–17604
Mundell SJ, Loudon R, Benovic JL (1999) Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels. Biochemistry 38:8723–8732
Ahn S, Nelson CD, Runyan Garrison T et al (2003) Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference. Proc Natl Acad Sci U S A 100:1740–1744
Deshpande DA, Theriot BS, Penn RB et al (2008) β-arrestins specifically constrain β2-adrenergic receptor signaling and function in airway smooth muscle. FASEB J 22:2134–2141
Perez-Reyes N, Halbert CL, Smith PP et al (1992) Immortalization of primary human smooth muscle cells. Proc Natl Acad Sci U S A 89:1224–1228
Brighton PJ, Rana S, Challiss RA et al (2011) Arrestins differentially regulate histamine- and oxytocin-evoked phospholipase C and mitogen-activated protein kinase signalling in myometrial cells. Br J Pharmacol 162:1603–1617
Grotegut CA, Feng L, Mao L et al (2011) β-arrestin mediates oxytocin receptor signaling, which regulates uterine contractility and cellular migration. Am J Physiol Endocrinol Metab 300:E468–E477
DeFea KA (2011) β-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell Signal 23:621–629
Zhang X, Wang F, Chen X et al (2005) β-arrestin1 and β-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of δ-opioid receptors. J Neurochem 95:169–178
Shukla AK, Violin JD, Whalen EJ et al (2008) Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors. Proc Natl Acad Sci U S A 105:9988–9993
McDonald PH, Chow CW, Miller WE et al (2000) β-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290:1574–1577
DeFea KA, Zalevsky J, Thoma JS et al (2000) β-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267–1281
Luttrell LM, Roudabush FL, Choy EW et al (2001) Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc Natl Acad Sci U S A 98:2449–2454
Wei H, Ahn S, Shenoy S et al (2003) Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci U S A 100:10782–10787
Kohout TA, Nicholas SL, Perry SJ et al (2004) Differential desensitization, receptor phosphorylation, β-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem 279:23214–23222
Zidar DA, Violin JD, Whalen EJ et al (2009) Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc Natl Acad Sci U S A 106:9649–9654
Sun Y, Cheng Z, Ma L et al (2002) β-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 277:49212–49219
Bruchas MR, Macey TA, Lowe JD et al (2006) Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem 281:18081–18089
Gong K, Li Z, Xu M et al (2008) A novel protein kinase A-independent, β-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by β2-adrenergic receptors. J Biol Chem 283:29028–29036
Lynch MJ, Baillie GS, Mohamed A et al (2005) RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with β arrestin to control the protein kinase A/AKAP79-mediated switching of the β2-adrenergic receptor to activation of ERK in HEK293B2 cells. J Biol Chem 280:33178–33189
Barnes WG, Reiter E, Violin JD et al (2005) β-arrestin 1 and Gαq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem 280:8041–8050
Cheung R, Malik M, Ravyn V et al (2009) An arrestin-dependent multi-kinase signaling complex mediates MIP-1β/CCL4 signaling and chemotaxis of primary human macrophages. J Leukoc Biol 86:833–845
Zoudilova M, Kumar P, Ge L et al (2010) β-arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of protease-activated receptor-2. J Biol Chem 285:14318–14329
Kim J, Ahn S, Ragajopal K et al (2009) Independent β-arrestin2 and Gq/protein kinase Cζ pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor. J Biol Chem 284:11953–11962
McLennan GP, Kiss A, Miyatake M et al (2008) Kappa opioids promote the proliferation of astrocytes via Gβγ and β-arrestin 2-dependent MAPK-mediated pathways. J Neurochem 107:1753–1765
Heinrich EL, Lee W, Lu J et al (2012) Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J Transl Med 10:68
Talbot J, Joly E, Prentki M et al (2012) β-Arrestin1-mediated recruitment of c-Src underlies the proliferative action of glucagon-like peptide-1 in pancreatic beta INS832/13 cells. Mol Cell Endocrinol 364:65–70
Willets JM (2011) Approaches to study GPCR regulation in native systems. Methods Mol Biol 746:99–112
Watts JK, Deleavey GF, Damha MJ (2008) Chemically modified siRNA: tools and applications. Drug Discov Today 13:842–855
Kole R, Krainer AR, Altman S (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11:125–140
Jeong JH, Park TG, Kim SH (2011) Self-assembled and nanostructured siRNA delivery systems. Pharm Res 28:2072–2085
Makinen PI, Koponen JK, Karkainen AM et al (2006) Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J Gene Med 8:433–441
Reiter E, Ahn S, Shukla AK et al (2012) Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179–197
Kenakin T (2010) G protein coupled receptors as allosteric proteins and the role of allosteric modulators. J Recept Signal Transduct Res 30:313–321
Walters RW, Shukla AR, Kovacs JJ et al (2009) β-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest 119:1312–1321
Acknowledgments
The authors declare that they have no conflict of interest financial or otherwise. They would also like to thank the British Heart Foundation for continued funding.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Willets, J., Nash, C. (2014). Investigation of G Protein-Coupled Receptor Function and Regulation Using Antisense. In: Stevens, C. (eds) G Protein-Coupled Receptor Genetics. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-779-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-62703-779-2_6
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-778-5
Online ISBN: 978-1-62703-779-2
eBook Packages: Springer Protocols